shotgun < should < shoulder

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by should

Number of relevant bibliographic references: 285.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000002 (2020)	L. Horvath [Allemagne] ; B. Hellmich [Allemagne]	[Treatment of giant cell arteritis and polymyalgia rheumatica].
000050 (2020)	Daichi Fukaya [Japon] ; Tsutomu Inoue [Japon] ; Yuta Kogure [Japon] ; Hiroshi Kajiyama [Japon] ; Keisuke Ishizawa [Japon] ; Takeru Seto [Japon] ; Hajime Hasegawa [Japon] ; Toshihide Mimura [Japon] ; Hirokazu Okada [Japon]	Tocilizumab-induced immunocomplex glomerulonephritis: a report of two cases.
000051 (2020)	Eun Hye Park [Corée du Sud] ; Eun Young Lee [Corée du Sud] ; Kichul Shin [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud]	Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
000082 (2020)	Eun-Jung Park [Corée du Sud] ; Hyungjin Kim [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Yoon-Kyoung Sung [Corée du Sud] ; Han Joo Baek [Corée du Sud] ; Jisoo Lee [Corée du Sud]	The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
000141 (2020)	Adam Amlani [Canada] ; Claire Barber [Canada] ; Aurore Fifi-Mah [Canada] ; Jose Monzon [Canada]	Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of Literature.
000152 (2020)	Alfredo Sadun [États-Unis] ; Lynn Gordon	Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?
000153 (2020)	Luca Perico ; Ariela Benigni ; Giuseppe Remuzzi	Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade
000169 (2020)	Maria Antonietta Barbieri [Italie] ; Giuseppe Cicala [Italie] ; Paola Maria Cutroneo [Italie] ; Elisabetta Gerratana [Italie] ; Caterina Palleria [Italie] ; Caterina De Sarro [Italie] ; Ada Vero [Italie] ; Luigi Iannone [Italie] ; Antonia Manti [Italie] ; Emilio Russo [Italie] ; Giovambattista De Sarro [Italie] ; Fabiola Atzeni [Italie] ; Edoardo Spina [Italie]	Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study.
000176 (2020)	Giuseppe Magro	SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
000187 (2020)	Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan ; Olena Zimba [Ukraine]	Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
000194 (2020)	Alimuddin Zumla [Royaume-Uni] ; David S. Hui [République populaire de Chine] ; Esam I. Azhar [Arabie saoudite] ; Ziad A. Memish [Arabie saoudite] ; Markus Maeurer [Portugal, Allemagne]	Reducing mortality from 2019-nCoV: host-directed therapies should be an option
000197 (2020)	Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie]	Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
000206 (2020)	Christos Koutsianas ; Konstantinos Thomas ; Dimitrios Vassilopoulos	Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
000267 (2020)	Emanuele Nicastri ; Nicola Petrosillo ; Tommaso Ascoli Bartoli ; Luciana Lepore ; Annalisa Mondi ; Fabrizio Palmieri ; Gianpiero D Ffizi ; Luisa Marchioni ; Silvia Murachelli ; Giuseppe Ippolito ; Andrea Antinori	National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
000273 (2020)	Zheng Wang [États-Unis] ; Yicheng Zhao [États-Unis] ; Zhiqiang An [États-Unis] ; Wenliang Li [États-Unis]	Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
000274 (2020)	Meng Hsuan Kuo [Taïwan] ; Chih-Wei Tseng [Taïwan] ; Chi-Hui Lee [Taïwan] ; Chien-Hsueh Tung [Taïwan] ; Kuo-Chih Tseng [Taïwan] ; Ning-Sheng Lai [Taïwan]	Moderate Risk of Hepatitis B Virus Reactivation in HBsAg−/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis
000281 (2020)	Haihua Zhang [République populaire de Chine] ; Tao Wang [République populaire de Chine] ; Zhifa Han [République populaire de Chine] ; Guiyou Liu [République populaire de Chine]	Mendelian randomization study to evaluate the effects of interleukin-6 signaling on four neurodegenerative diseases.
000301 (2020)	Austin R. Morrison ; Joseph M. Johnson ; Mayur Ramesh ; Patrick Bradley ; Jeffery Jennings ; Zachary R. Smith	Letter to the Editor: Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab.
000364 (2020)	Ahmed Virani [États-Unis] ; Erica Rabold [États-Unis] ; Taylor Hanson [États-Unis] ; Aaron Haag [États-Unis] ; Rawiya Elrufay [États-Unis] ; Tariq Cheema [États-Unis] ; Marvin Balaan [États-Unis] ; Nitin Bhanot [États-Unis]	Guillain-Barré Syndrome associated with SARS-CoV-2 infection
000394 (2020)	Alberto Meneguzzo ; Annalisa Lazzarotto ; Mauro Alaibac	Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer
000400 (2020)	Muhammad Aziz [États-Unis] ; Rawish Fatima [États-Unis] ; Ragheb Assaly [États-Unis]	Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "should" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "should" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    should
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021